Cambridge Consultants, as part of the Continua Health Alliance, has announced the development of the Vena platform. Vena is a single-chip communications solution for health devices, with the capability to provide wired (USB) and wireless (Bluetooth) connectivity to health devices. ...

Pioneering research by UK scientists shows that a new product – Rember – may slow the progress of mild to moderate Alzheimer’s disease by 81% over a year and could offer hope to millions worldwide. Rember is the first drug ...

Do you like being under pressure? Do you enjoy running around like a mouse on a wheel? Think again. Scientists from UCLA have discovered a cellular mechanism linking between stress, aging, and illness. This discovery could potentially help create drugs ...

The Swiss Company Debiotech has developed a tiny insulin pump to deliver accurate drug quantities over a long time. The pump, 65 millimeters in size, sucks the drug from a container and injects it to the body. The device is ...

The San Francisco based biopharmaceutical company Medivation has recently published results of its first pivotal clinical trial of Dimebon in Alzheimer’s disease. Dimebon, a drug formerly approved as an allergy treatment, demonstrated statistically significant improvement over placebo in memory, thinking, ...

King’s College, London is developing a new technology that may make the dentist’s drill obsolete in as little as five years. A preliminary study shows that decay causing bacteria scatter light differently from healthy tooth matter. Using a form of ...

Scientists from the National Institute of Standards and Technology (NIST) and the National Institutes of Health (NIH) have developed customized microscopic magnets called microtags that might one day be injected into the body and make magnetic resonance imaging (MRI) colorful. ...

The Texas based Company Motion Computing has recently announced that its clinically oriented C5 tablet PC has been upgraded and fortified with a new solid-state drive (SSD). The C5 also includes integrated mobile broadband that extends its usability to the ...

A research team from the Hadassah Medical Organization and the Hebrew University in Jerusalem has developed a method for generating a personalized melanoma vaccination. The vaccination is targeted at patients in the early stages of tumor development and for patients ...

A group of scientists from the School of Medicine at the University of California (UCLA), Los Angeles has shown that a drug usually used in patients after organ transplantations has reversed signs of mental retardation in mice. The scientists hope ...